Newstral
Brainstorm Cell Therapeutics Inc.
- BrainStorm Cell Therapeutics to Present at the 29th International Symposium on ALS/MNDcapitolhilltimes.com
- MMeet the one patient who will get access to this experimental ALS therapy before it’s approvedmarketwatch.com
- Under “right-to-try” law, therapy may go for $300K—with no proof it will workArs Technica
Frequent names
Newstral's extraction of names of people and organisations from the world's news is completely automated. If you do not want your name to appear here, please contact us. We will be happy to look at your request.